Please assess the completion status of the following clinical trial:

Trial Title: TMS Measures of Plasticity and Excitatory/Inhibitory Ratio as Biomarkers: R-baclofen Effects in Normal Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Age: 18-30~* IQ: higher than 85~* Normal physical examination~Exclusion Criteria~* significant medical problems~* ongoing medications~* All female participants are required to have a negative pregnancy test

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- sugar pill (Type: PLACEBO_COMPARATOR): placebo administered under double blind conditions
- 3 mg of R-baclofen (Type: EXPERIMENTAL): 3 mg of R-Baclofen administered double blind
- 10 mg of R-baclofen (Type: EXPERIMENTAL): 10 mg of R-baclofen administered double-blind
- 25 mg of R-baclofen (Type: EXPERIMENTAL): 25 mg of R-baclofen administered double blind
- second sugar pill (Type: PLACEBO_COMPARATOR): the second placebo administered double blind

Based on this trial design, predict the completion outcome and termination type (if applicable).